The global clinical nutrition market is experiencing remarkable growth, driven by factors such as the rising prevalence of chronic diseases, increasing geriatric population, and growing awareness about the importance of specialized nutrition. Valued at USD 49.77 billion in 2024, this market is set to grow at a Compound Annual Growth Rate (CAGR) of 8% during the forecast period from 2025 to 2034. By the end of this period, the market is expected to reach a value of USD 99.16 billion.
In this article, we will explore the major trends driving the market, key players, innovations in clinical nutrition products, and provide answers to some frequently asked questions (FAQs) related to this growing industry. We will also dive deep into the various segments of the clinical nutrition market, such as enteral nutrition, parenteral nutrition, and pediatric nutrition, and provide insight into the regulatory landscape and growth strategies.
What is Clinical Nutrition?
Clinical nutrition refers to the use of specially formulated nutrients that help manage medical conditions or support health recovery. Unlike regular food or supplements, clinical nutrition products are designed for patients with specific nutritional requirements, often due to illnesses or medical treatments. These products include oral nutritional supplements (ONS), enteral (tube) feeding, and parenteral (intravenous) nutrition, aimed at improving the health outcomes of patients with chronic diseases, malnutrition, or other health challenges.
Get a Free Sample Report with Table of Contents : https://www.expertmarketresearch.com/reports/clinical-nutrition-market/requestsample
Market Drivers for Clinical Nutrition
The global clinical nutrition market is growing due to several key factors, including:
1. Increasing Prevalence of Chronic Diseases
Chronic diseases such as diabetes, cardiovascular diseases, cancer, and neurological disorders require specialized nutrition to manage symptoms, support treatment outcomes, and improve patients' quality of life. As the incidence of these diseases continues to rise worldwide, the demand for clinical nutrition products is expected to grow. The World Health Organization (WHO) estimates that chronic diseases are responsible for 71% of global deaths, further driving the need for targeted nutritional support.
2. Ageing Population
The global population is ageing, particularly in developed countries. Older adults are more likely to experience malnutrition or require special nutritional interventions due to age-related health issues. As the elderly population grows, so too does the demand for clinical nutrition to support their health and manage age-related conditions like sarcopenia, osteoporosis, and frailty.
3. Growing Awareness of Nutritional Therapy
With increasing awareness about the role of nutrition in healthcare, more patients and healthcare providers are turning to clinical nutrition as part of treatment plans. This trend is particularly evident in hospitals, rehabilitation centers, and homecare environments where patients are monitored closely for nutritional needs.
4. Technological Advancements in Nutrition Delivery
Recent technological advancements in the delivery of clinical nutrition, such as portable feeding devices and improved parenteral nutrition techniques, are making it easier to provide patients with necessary nutrients. These innovations are expanding the scope of clinical nutrition treatments in hospitals and home settings.
5. Rising Healthcare Expenditures
The global rise in healthcare spending, particularly in emerging markets, is also contributing to the growth of the clinical nutrition market. Governments and private health sectors are increasingly investing in the infrastructure needed to provide better nutritional care to patients.
Key Segments of the Global Clinical Nutrition Market
The clinical nutrition market can be broken down into several key segments, each with its own unique growth drivers and challenges:
1. Enteral Nutrition
Enteral nutrition refers to feeding via a tube, directly into the gastrointestinal tract. This method is used for patients who cannot ingest food orally due to conditions like stroke, cancer, or neurological diseases. Enteral nutrition includes both liquid formulations (such as oral nutritional supplements) and tube feeding formulas. The market for enteral nutrition is expected to grow due to the increasing demand for homecare solutions and a greater understanding of its role in managing chronic diseases.
2. Parenteral Nutrition
Parenteral nutrition involves delivering nutrients directly into the bloodstream, bypassing the digestive system. It is typically used in patients who cannot absorb nutrients through their gastrointestinal tract, such as those with gastrointestinal disorders, post-surgical patients, and critically ill patients. As healthcare infrastructure improves, particularly in developing regions, the demand for parenteral nutrition is expected to increase.
3. Pediatric Nutrition
Pediatric nutrition includes products designed for infants, children, and adolescents with special nutritional needs. This segment is particularly important for children suffering from malnutrition, prematurity, or congenital conditions. The growing prevalence of childhood obesity and metabolic disorders is driving the need for specialised clinical nutrition products tailored for younger populations.
4. Oral Nutritional Supplements (ONS)
Oral nutritional supplements are designed for individuals who require additional calories, protein, and other essential nutrients but are not able to meet their needs through regular food. These supplements are widely used in hospitals, nursing homes, and home settings. With increasing awareness of the importance of good nutrition, the ONS segment is expanding rapidly.
Key Players in the Global Clinical Nutrition Market
The clinical nutrition market is highly competitive, with several global and regional players leading the way. These companies focus on developing innovative products, acquiring smaller brands, and expanding their market presence in emerging regions. Some of the key players include:
1. Abbott Laboratories
Abbott is a leader in the clinical nutrition market, with a broad portfolio of products across enteral and parenteral nutrition. Abbott's product offerings include the well-known Ensure and Glucerna brands, which cater to a wide range of patients, from those requiring general nutritional support to those with chronic conditions like diabetes.
2. Nestlé Health Science
Nestlé Health Science is a global leader in the clinical nutrition space, providing a range of products aimed at improving the health of patients with specific nutritional needs. Their portfolio includes brands such as Boost and Peptamen, which are designed for patients with gastrointestinal or malabsorption issues.
3. Danone Nutricia
Danone Nutricia offers a comprehensive range of enteral nutrition products, including those aimed at paediatric and adult populations. Their brands, such as Nutricia and Neocate, are well-regarded in both hospital and homecare settings for their focus on specialised nutrition for patients with critical conditions.
4. Fresenius Kabi
Fresenius Kabi, a division of the German healthcare giant Fresenius, provides a wide variety of clinical nutrition products, including both parenteral and enteral nutrition options. The company has a strong presence in hospitals worldwide, particularly in the areas of cancer, intensive care, and post-surgery recovery.
5. B. Braun Melsungen
B. Braun is a key player in the clinical nutrition market, offering a variety of intravenous nutrition products. The company also provides equipment for the safe delivery of nutrition through parenteral and enteral methods. B. Braun’s focus is on patient safety and the development of high-quality nutritional products.
Challenges in the Clinical Nutrition Market
Despite the promising growth prospects, the clinical nutrition market faces a few challenges:
-
Regulatory Hurdles
The clinical nutrition market is heavily regulated, with strict guidelines on product formulations and delivery methods. Navigating these regulations can be challenging for new players looking to enter the market. -
High Costs
Clinical nutrition products, particularly those administered intravenously or enterally, can be expensive. This makes them less accessible to patients in low-income regions and puts a strain on healthcare systems that already have limited resources. -
Lack of Awareness in Emerging Markets
While the clinical nutrition market is growing, awareness about the importance of specialised nutrition is still limited in many emerging economies. Expanding access to education and information will be crucial for further market growth.
FAQs
1. What is the projected growth rate of the clinical nutrition market?
The clinical nutrition market is projected to grow at a CAGR of 8% from 2025 to 2034, reaching a value of USD 99.16 billion by 2034.
2. What factors are driving the growth of the clinical nutrition market?
The increasing prevalence of chronic diseases, the ageing population, advancements in nutrition delivery technology, and rising healthcare expenditures are the key drivers.
3. What are the main segments of the clinical nutrition market?
The main segments include enteral nutrition, parenteral nutrition, oral nutritional supplements, and pediatric nutrition.
4. Who are the leading players in the clinical nutrition market?
Key players include Abbott Laboratories, Nestlé Health Science, Danone Nutricia, Fresenius Kabi, and B. Braun Melsungen.
5. How does clinical nutrition help patients with chronic diseases?
Clinical nutrition provides essential nutrients that support recovery, manage symptoms, and improve overall health outcomes in patients with chronic diseases.